North Wales, PA, United States of America

Thomas Joseph Tucker

USPTO Granted Patents = 35 

 

 

Average Co-Inventor Count = 8.3

ph-index = 7

Forward Citations = 174(Granted Patents)


Location History:

  • West Point, PA (US) (2017 - 2021)
  • North Wales, PA (US) (1987 - 2024)

Company Filing History:


Years Active: 1987-2025

Loading Chart...
Loading Chart...
Loading Chart...
35 patents (USPTO):

Title: The Innovative Contributions of Thomas Joseph Tucker in Cardiovascular Research

Introduction: Thomas Joseph Tucker, based in North Wales, PA, has made significant strides in the field of cardiovascular research through his numerous patents. With a total of 34 patents under his name, Tucker's work focuses on devising innovative compounds that target critical health issues, particularly those related to PCSK9 activity.

Latest Patents: Among his most recent patents, Tucker has disclosed various compounds that act as PCSK9 antagonists. The patents include detailed descriptions of compounds of Formula I and Formula A, along with their pharmaceutically acceptable salts. These compounds have shown promise in antagonizing PCSK9, which plays a vital role in lipid metabolism. The patents also encompass pharmaceutical formulations comprising these compounds and methods for treating cardiovascular diseases such as atherosclerosis, hypercholesterolemia, coronary heart disease, and metabolic syndromes.

Career Highlights: Throughout his career, Thomas Joseph Tucker has been associated with prominent pharmaceutical companies, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His innovative contributions have paved the way for effective treatment methods that address serious cardiovascular conditions, showcasing his commitment to enhancing public health.

Collaborations: Tucker's work has often been supported by collaborative efforts with distinguished peers in the industry. Notable collaborators include William C. Lumma, Jr. and John T. Sisko, with whom he has worked to further advance research in cardiovascular health and the development of novel therapeutic compounds.

Conclusion: Thomas Joseph Tucker stands out as a key inventor in the realm of PCSK9 antagonist compounds, reflecting his dedication to innovation and improvement in cardiovascular medicine. His extensive portfolio of patents not only highlights his expertise but also contributes significantly to the pursuit of effective treatments for common yet critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…